MDs not returning to Idaho; Experimental drug could fight MRSA;

> At Hospital Impact, Nick Jacobs discusses what he'll miss as a hospital CEO. Article

> An Idaho program to train more doctors for the state is producing more MDs-but many aren't returning to Idaho after completing their education. Article

> A new study finds that a single, large dose of an experimental antibiotic called oritavancin could be effective in fighting MRSA infections. Report

> The GAO has found that the FDA doesn't do enough to monitor drugs produced overseas, which could lead to unsafe treatments being distributed in the U.S. Report

And Finally... After 10 years of work, Living Cell Technologies in New Zealand has received the green light from the government to launch an unusual human trial of a new diabetes therapy. Report

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.